nl_e17

Vol. 51 / RR-6 Recommendations and Reports 77
94. American College of Obstetricians and Gynecologists. Routine cancer
screening: committee opinion 185. Washington, DC: American
College of Obstetricians and Gynecologists, 1997.
95. National Cancer Institute Workshop. The 1988 Bethesda System for
reporting cervical/vaginal cytological diagnoses. JAMA 1989;262:931–4.
96. Jay N, Moscicki AB. Human papillomavirus infections in women with
HIV disease: prevalence, risk, and management [Review]. AIDS Reader
2000;10:659–68.
97. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH,
National Cancer Institute Workshop. Interim guidelines for management
of abnormal cervical cytology. JAMA 1994;271:1866–9.
98. MacKellar DA, Valleroy LA, Secura GM, et al. Two decades after vaccine
license: hepatitis B immunization and infection among young
men who have sex with men. Am J Public Health 2001;91:965–71.
99. CDC. Immunization of adolescents: recommendations of the Advisory
Committee on Immunization Practices, the American Academy
of Pediatrics, the American Academy of Family Physicians, and the
American Medical Association. MMWR 1996;45:1–5.
100. Mast EE, Williams IT, Alter MJ, Margolis HS. Hepatitis B vaccination
of adolescent and adult high-risk groups in the United States.
Vaccine 1998;16(Suppl):S27–S29.
101. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of
hepatitis C virus infection in the United States, 1988 through 1994.
N Engl J Med 1999;341:556–62.
102. CDC. Recommendations for prevention and control of hepatitis
C virus (HCV) infection and HCV-related chronic disease. MMWR
1998;47(No.RR-19):1–39.
103. Diegstag JL. Sexual and perinatal transmission of hepatitis C.
Hepatology 1997:26(Suppl 1):S66–S70.
104. Alter MJ. Epidemiology of hepatitis C. Hepatology 1999;26
(Suppl 1):S25–S65.
105. Thomas DL, Zenilman JM, Alter MJ, et al. Sexual transmission of
hepatitis C virus among patients attending Baltimore sexually transmitted
disease clinics: an analysis of 309 sex partnerships. J Infect Dis
1995;171:768–75.
106. Hisada M, O’Brien TR, Rosenberg PS, Goedert JJ. Virus load and risk
of heterosexual transmission of human immunodeficiency virus and
hepatitis C virus by men with hemophilia: the Multicenter Hemophilia
Cohort Study. J Infect Dis 2000;181:1475–8.
107. Bamberger JD, Waldo CR, Gerberding JL, Katz MH. Postexposure
prophylaxis for human immunodeficiency virus (HIV) infection
following sexual assault. Am J Med 1999;106:323–6.
108. CDC. Public Health Service guidelines for the management of health
care worker exposures to HIV and recommendations for post-exposure
prophylaxis. MMWR 1998;47(No. RR-7):1–33.
109. American Academy of Pediatrics. Sexually transmitted disease in
adolescents and children. In: Pickering LK, ed. 2000 Red book: report
of the Committee on Infectious Diseases. 25 th ed. Elk Grove Village,
IL: American Academy of Pediatrics, 2000:138–47.
110. American Academy of Pediatrics Committee on Child Abuse and
Neglect. Guidelines for the evaluation of sexual abuse of children:
subject review. Pediatrics 1999;103:186–91.
111. Adams JA, Harper K, Krudson S. A proposed system for the classifications
of anogenital findings in children with suspected child abuse. Adolesc
Pediatr Gynecol 1992;5:73–5.
112. Shapiro RA, Schubert CJ, Siegel R. Neisseria gonorrhoeae infections in
girls younger than 12 years of age evaluated for vaginitis. Pediatrics
1999;104:(e72):1–11.
113. Lagerberg D. Sexually transmitted diseases in children: a serious consequence
of sexual abuse and an indication of possible victimization of
other children. Acta Pediatrica 1998;87:1214–7.
114. Dominguez KL, Simonds RJ. Postexposure prophylaxis. In: Zeichner
SL, Read JS, eds. Handbook of pediatric HIV care. Philadelphia:
Lippincott Williams & Wilkins, 1999:294–318.
Abbreviations Used
in This Publication
ACIP Advisory Committee on Immunization Practices
ACOG American College of Obstetricians and
Gynecologists
ACS American Cancer Society
AIDS Acquired immunodeficiency syndrome
ALT Alanine aminotransferase
anti-HBc Antibody to the hepatitis B core antigen
ASCUS Atypical squamous cells of undetermined
significance
BCA Bichloroacetic acid
BV Bacterial vaginosis
CBC Complete blood count
CDC Centers for Disease Control and Prevention
CI Confidence interval
CIN Cervical intraepithelial neoplasia
CLD Chronic liver disease
CMV Cytomegalovirus
CNS Central nervous system
CSF Cerebrospinal fluid
d4T Stavudine
ddC Dideoxycytodine
ddI Didanosine
DFA Direct fluorescent antibody
DGI Disseminated gonococcal infection
dL Deciliter
DNA Deoxyribonucleic acid
EIA Enzyme immunoassay
ELISA Enzyme-linked immunosorbent assay
FDA Food and Drug Administration
FTA-ABS Fluorescent treponemal antibody absorbed
gG glycoprotein G
GISP Gonococcal Isolate Surveillance Project
HAV Hepatitis A virus
HBIG Hepatitis B immune globulin
HBsAg Hepatitis B surface antigen
HBV Hepatitis B virus
HCV Hepatitis C virus
HIV Human immunodeficiency virus
HPV Human papillomavirus